Korean Post Marketing Surveillance To Observe Effectiveness And Safety Of Pristiq (Registered) In Patients With Major Depressive Disorder.

Trial Profile

Korean Post Marketing Surveillance To Observe Effectiveness And Safety Of Pristiq (Registered) In Patients With Major Depressive Disorder.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Aug 2017

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PMS
  • Sponsors Pfizer
  • Most Recent Events

    • 11 May 2016 Status changed from not yet recruiting to recruiting.
    • 07 Mar 2016 Planned initiation date changed from 1 Apr 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.
    • 11 Dec 2015 Planned initiation date changed from 1 Dec 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top